C Mee Ling Munier

Summary

Publications

  1. doi request reprint HIV vaccines: progress to date
    C Mee Ling Munier
    HIV Immunovirology Laboratory, St Vincent s Centre for Applied Medical Research, Sydney, New South Wales, Australia
    Drugs 71:387-414. 2011
  2. doi request reprint Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses
    Nabila Seddiki
    The Kirby Institute, University of New South Wales, Sydney, NSW, Australia St Vincent s Centre for Applied Medical Research, Sydney, NSW, Australia
    Eur J Immunol 44:1644-61. 2014
  3. doi request reprint The role of T cell immunity in HIV-1 infection
    C Mee Ling Munier
    The Kirby Institute for Infection and Immunity in Society, University of NSW, Sydney, NSW, Australia
    Curr Opin Virol 3:438-46. 2013

Detail Information

Publications3

  1. doi request reprint HIV vaccines: progress to date
    C Mee Ling Munier
    HIV Immunovirology Laboratory, St Vincent s Centre for Applied Medical Research, Sydney, New South Wales, Australia
    Drugs 71:387-414. 2011
    ..Understanding the biology and immunopathology of HIV-1 early following infection, its modes of transmission and the human immune system's response to the virus should aid in the rational design of vaccines of increased efficacy...
  2. doi request reprint Human antigen-specific CD4⁺ CD25⁺ CD134⁺ CD39⁺ T cells are enriched for regulatory T cells and comprise a substantial proportion of recall responses
    Nabila Seddiki
    The Kirby Institute, University of New South Wales, Sydney, NSW, Australia St Vincent s Centre for Applied Medical Research, Sydney, NSW, Australia
    Eur J Immunol 44:1644-61. 2014
    ..Identification and isolation of these cells enables the role of Treg cells in memory responses to be further defined and provides a development pathway for novel therapeutics. ..
  3. doi request reprint The role of T cell immunity in HIV-1 infection
    C Mee Ling Munier
    The Kirby Institute for Infection and Immunity in Society, University of NSW, Sydney, NSW, Australia
    Curr Opin Virol 3:438-46. 2013
    ..These efforts are providing opportunities for development of novel therapies and vaccines. ..